BREAKING

MainStreet Bancshares Releases Q1 2026 Financial Results 29 minutes ago Nano-X Imaging Blows Past Q4 2025 Forecasts: vs -$0.20 Expected 35 minutes ago Capital City Bank Group Releases Q1 2026 Financial Results 2 hours ago Cleveland-Cliffs Releases Q1 2026 Financial Results 2 hours ago Ennis Releases Q4 2026 Financial Results 2 hours ago Cavco Industries Jumps 7.1% Amid Sector-Wide Rally 3 days ago Materion Jumps 7.7% Amid Sector-Wide Selling 3 days ago Advanced Drainage Systems Jumps 7.7% Amid Sector-Wide Rally 3 days ago AeroVironment Drops 6.3% Amid Sector-Wide Selling 3 days ago WaFd Jumps 7.5% Amid Sector-Wide Selling 3 days ago MainStreet Bancshares Releases Q1 2026 Financial Results 29 minutes ago Nano-X Imaging Blows Past Q4 2025 Forecasts: vs -$0.20 Expected 35 minutes ago Capital City Bank Group Releases Q1 2026 Financial Results 2 hours ago Cleveland-Cliffs Releases Q1 2026 Financial Results 2 hours ago Ennis Releases Q4 2026 Financial Results 2 hours ago Cavco Industries Jumps 7.1% Amid Sector-Wide Rally 3 days ago Materion Jumps 7.7% Amid Sector-Wide Selling 3 days ago Advanced Drainage Systems Jumps 7.7% Amid Sector-Wide Rally 3 days ago AeroVironment Drops 6.3% Amid Sector-Wide Selling 3 days ago WaFd Jumps 7.5% Amid Sector-Wide Selling 3 days ago

ADVERTISEMENT

BO

BOLD

All BOLD Content

1 articles, transcripts, and reports

USB

Breaking News

Boundless Bio (BOLD) Posts First Revenue of $17.3M, Narrows Q4 Loss to $0.58/Share

Boundless Bio narrows Q4 loss to $0.58/share and posts first-ever revenue of $17.3M, guiding to $78-80M for 2026.

March 9, 20262 min read